Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.

Liam BendicksenAaron S Kesselheim

Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2023)

Legal challenges to the FDA's approval of mifepristone have destabilized patients' ability to access controversial medicines like medication abortion. We argue that federal courts' receptiveness to this litigation undermines the coherence and integrity of prescription drug regulation in the U.S.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
peritoneal dialysis
emergency department
patient reported outcomes
patient reported